Alpine Global Management, LLC Cor Medix Inc. Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 06, 2024	BUY	$3.94 - $5.8 $78,800 - $116,000	20,000 New	20,000 $79,000
Q2 2023 Nov 21, 2023	BUY	$3.94 - $5.8 $78,800 - $116,000	20,000 New	20,000 $79,000
Q2 2023 Aug 14, 2023	BUY	$3.94 - $5.8 $78,800 - $116,000	20,000 New	20,000 $79,000
Q4 2020 Feb 12, 2021	SELL	$5.0 - $9.15 $94,195 - $172,376	-18,839 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$3.96 - $6.15 $74,602 - $115,859	18,839 New	18,839 $114,000

120

18.3M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $405M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.